atropine 0.778 MG/ML

RxCUI
1664972
RxNorm name
atropine 0.778 MG/ML
Term type
SCDC
Status
Active
Updated
2026-10-20 20:50:47

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102015
Active start
102015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
0.778 MG / 1 MLatropine

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
atropine1223

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRatropine 0.778 MG/ML1NAMES
RxNorm Nameatropine 0.778 MG/ML1NAMES
TTYSCDC1ATTRIBUTES
RxCUI16649721CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01FAAnticholinergicsATC1-4atropine
ATCV03ABAntidotesATC1-4atropine / pralidoxime
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4atropine
FDASPLN0000175574AnticholinergicEPChas_epcatropine
FDASPLN0000175700Cholinergic Muscarinic AntagonistEPChas_epcatropine
FDASPLN0000175370Cholinergic AntagonistsMOAhas_moaatropine
FDASPLN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine
MEDRTD001285AtropineCHEMhas_ingredientatropine
MEDRTD001249AsthmaDISEASEci_withatropine
MEDRTD001919BradycardiaDISEASEmay_treatatropine
MEDRTD003093Colitis, UlcerativeDISEASEci_withatropine
MEDRTD004342Drug HypersensitivityDISEASEci_withatropine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatatropine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withatropine
MEDRTD006323Heart ArrestDISEASEmay_treatatropine
MEDRTD006327Heart BlockDISEASEci_withatropine
MEDRTD007415Intestinal ObstructionDISEASEci_withatropine
MEDRTD007499Iris DiseasesDISEASEci_withatropine
MEDRTD007674Kidney DiseasesDISEASEci_withatropine
MEDRTD007905Lens DiseasesDISEASEci_withatropine
MEDRTD008107Liver DiseasesDISEASEci_withatropine
MEDRTD008532Megacolon, ToxicDISEASEci_withatropine
MEDRTD009157Myasthenia GravisDISEASEci_withatropine
MEDRTD015878MydriasisDISEASEinducesatropine
MEDRTD011041PoisoningDISEASEmay_treatatropine
MEDRTD012848Sinoatrial BlockDISEASEmay_treatatropine
MEDRTD013276Stomach UlcerDISEASEmay_treatatropine
MEDRTD013610TachycardiaDISEASEci_withatropine
MEDRTD013971ThyrotoxicosisDISEASEci_withatropine
MEDRTD000267Tissue AdhesionsDISEASEci_withatropine
MEDRTD014517Ureteral ObstructionDISEASEci_withatropine
MEDRTD014605UveitisDISEASEmay_treatatropine
MEDRTD014987XerostomiaDISEASEinducesatropine
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_peatropine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_peatropine
MEDRTN0000009808Positive ChronotropyPEhas_peatropine
MEDRTN0000009820Pupillary DilationPEhas_peatropine
MEDRTN0000009842Salivation InhibitionPEhas_peatropine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH0.778 MG/ML